{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Figure out how to get clinical trials in clinicaltrials.gov"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "file_path = \"../data/NCT05244993.json\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'NCT ID': 'NCT05244993',\n",
       " 'Brief Title': 'AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer',\n",
       " 'Brief Summary': 'This trial used a multicentre, single-arm design in which patients were treated with AK105 plus Anlotinib Hydrochloride combined with albumin paclitaxel. Patients included in this trial were advanced breast cancer with hormone receptor negative and Her2 negative. The primary endpoint is ORR, and the secondary endpoint is DCR, PFS, OS and safety.',\n",
       " 'Official Title': 'AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer',\n",
       " 'Conditions': ['Breast Neoplasm Female'],\n",
       " 'Interventions Description': ['AK105: 100mg per bottle, 200mg IV Day 1, cycled every 21 days',\n",
       "  'Anlotinib Hydrochloride: 12mg per capsule, 12 mg PO once daily on Days 1-14, cycled every 21 days',\n",
       "  'Albumin paclitaxel: 100mg per bottle, 125mg/m2 IV Days 1, 8, cycled every 21 days'],\n",
       " 'Eligibility': {'Healthy Volunteers': False,\n",
       "  'Sex': 'FEMALE',\n",
       "  'Minimum Age': '18 Years',\n",
       "  'Maximum Age': '75 Years',\n",
       "  'Standard Ages': ['ADULT', 'OLDER_ADULT'],\n",
       "  'Criteria Text ': 'Inclusion Criteria:\\n\\n* Female aged 18-75 years old.\\n* ECOG 0 or 1 point.\\n* Advanced triple-negative invasive breast cancer :\\n\\n  1. The pathological classification is triple negative, specifically:\\n\\n     1. ER negative: IHC\\\\<1%.\\n     2. PR negative: IHC\\\\<1%.\\n     3. HER2 negative: IHC-/+ or IHC++ but FISH/CISH is negative.\\n  2. Tumor staging: locally advanced or recurrent/metastatic breast cancer.\\n* If the last chemotherapy drug in the previous adjuvant/neoadjuvant treatment stage is paclitaxel, paclitaxel liposome, paclitaxel albumin or docetaxel, it will take ≥6 months from the end of treatment to enrollment.\\n* At least one objectively measurable lesion according to the RECIST 1.1 .\\n* The main organs are functioning well, and the blood test results within 14 days before enrollment should meet the following requirements:\\n\\n  1. Routine blood test:\\n\\n     1. Hemoglobin (HB) ≥90 g/L.\\n     2. Neutrophil count (ANC) ≥1.5×109/L.\\n     3. Platelet count (PLT) ≥100×109/L.\\n  2. Biochemical test:\\n\\n     1. Total bilirubin≤1.5×ULN (upper limit of normal).\\n     2. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5×ULN; if there is liver metastasis, ALT and AST ≤ 5×ULN.\\n     3. Serum creatinine (Cr) ≤1.5 ULN or creatinine clearance ≥60mL/min.\\n* Must not be regnant.\\n* Volunteer to participate in this study and sign an informed consent form.\\n\\nExclusion Criteria:\\n\\n* Pregnant, lactating or planning to become pregnant during the study period.\\n* Allergic to any of the drugs in the study.\\n* Previously received PD-1/PD-L1 antibody, CTLA-4 antibody, or anti-vascular targeted therapy.\\n* Central nervous system (CNS) metastases.\\n* Concomitant disease/medical history:\\n\\n  1. Patients with any known or suspected autoimmune diseases.\\n  2. Hypertension.\\n  3. Peripheral neuropathy ≥ Grade 2.\\n  4. Persons with a history of unstable angina or arrhythmia.\\n  5. Active or uncontrolled serious infection .\\n  6. History of immunodeficiency.\\n  7. Active hepatitis B or C.\\n  8. interstitial lung disease or non-infectious pneumonia.\\n  9. Active tuberculosis.\\n  10. Urine protein is ≥++, and 24-hour urine protein quantitative is \\\\>1.0g.\\n  11. Suffered from other malignant tumors within 5 years before enrollment.\\n  12. Unreduced toxicity .\\n  13. Multiple factors that affect oral medications.\\n  14. Abnormal coagulation function.\\n  15. Major surgical treatment, open biopsy or traumatic injury within 4 weeks.\\n  16. Tumor has invaded the periphery of important blood vessels.\\n  17. Patients who have seizures.\\n  18. Bleeding constitution or medical history.\\n  19. Arterial/venous thrombotic events before enrollment or within 6 months.\\n  20. Live attenuated vaccine vaccination within 28 days before the study.\\n  21. Uncontrollable pleural, abdominal or pericardial effusion.\\n  22. Other uncontrollable systemic diseases.\\n* Other serious physical or mental diseases or laboratory abnormalities.\\n* Patients who the researcher thinks are not suitable for this research.\\n* Participated in clinical trials of other anti-tumor drugs within four weeks.'}}"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import json\n",
    "\n",
    "def load_json_file(file_path):\n",
    "    \"\"\"\n",
    "    Load a JSON file from the specified file path and return the JSON object.\n",
    "    \n",
    "    :param file_path: str, path to the JSON file\n",
    "    :return: dict, loaded JSON object\n",
    "    \"\"\"\n",
    "    with open(file_path, 'r') as file:\n",
    "        json_data = json.load(file)\n",
    "    return json_data\n",
    "\n",
    "\n",
    "def process_clinical_trial_data(data):\n",
    "    \"\"\"\n",
    "    Process a JSON object of clinical trial data to extract relevant attributes.\n",
    "    \n",
    "    :param data: dict, JSON object of clinical trial data\n",
    "    :return: dict, structured summary of extracted information\n",
    "    \"\"\"\n",
    "    # Extract identification information\n",
    "    identification_info = data['protocolSection']['identificationModule']\n",
    "    \n",
    "    # Extract conditions\n",
    "    conditions_info = data['protocolSection']['conditionsModule']['conditions']\n",
    "    \n",
    "    # Extract interventions\n",
    "    interventions_list = data['protocolSection']['armsInterventionsModule']['interventions']\n",
    "    interventions_descriptions = [\n",
    "        intervention.get('description', 'No description provided') for intervention in interventions_list\n",
    "    ]\n",
    "    \n",
    "    # Extract eligibility information\n",
    "    eligibility_info = data['protocolSection']['eligibilityModule']\n",
    "    eligibility_criteria_text = eligibility_info.get('eligibilityCriteria', 'Not provided')\n",
    "\n",
    "    # Extract summary information\n",
    "    summary_info = data['protocolSection']['descriptionModule']['briefSummary']\n",
    "    \n",
    "    # Summarize the extracted information\n",
    "    extracted_info = {\n",
    "        'NCT ID': identification_info.get('nctId', 'Not provided'),\n",
    "        'Brief Title': identification_info.get('briefTitle', 'Not provided'),\n",
    "        'Brief Summary': summary_info if summary_info else 'Not provided',\n",
    "        'Official Title': identification_info.get('officialTitle', 'Not provided'),\n",
    "        'Conditions': conditions_info if conditions_info else 'Not provided',\n",
    "        'Interventions Description': interventions_descriptions,\n",
    "        'Eligibility': {\n",
    "            'Healthy Volunteers': eligibility_info.get('healthyVolunteers', 'Not specified'),\n",
    "            'Sex': eligibility_info.get('sex', 'Not specified'),\n",
    "            'Minimum Age': eligibility_info.get('minimumAge', 'Not specified'),\n",
    "            'Maximum Age': eligibility_info.get('maximumAge', 'Not specified'),\n",
    "            'Standard Ages': eligibility_info.get('stdAges', 'Not specified'),\n",
    "            'Criteria Text ': eligibility_criteria_text\n",
    "        }\n",
    "    }\n",
    "    \n",
    "    return extracted_info\n",
    "\n",
    "# Now we'll test the functions with the file we previously loaded\n",
    "json_data = load_json_file(file_path)\n",
    "clinical_trial_summary = process_clinical_trial_data(json_data)\n",
    "clinical_trial_summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "folder = \"ctg-studies.json\"\n",
    "\n",
    "# Go through all the json files in the folder and process them\n",
    "import os\n",
    "\n",
    "# def process_clinical_trials_folder(folder):\n",
    "#     \"\"\"\n",
    "#     Process a folder of JSON files containing clinical trial data.\n",
    "    \n",
    "#     :param folder: str, path to the folder containing the JSON files\n",
    "#     :return: list, list of structured summaries of extracted information\n",
    "#     \"\"\"\n",
    "#     clinical_trials_summaries = []\n",
    "#     for file in os.listdir(folder):\n",
    "#         file_path = os.path.join(folder, file)\n",
    "#         json_data = load_json_file(file_path)\n",
    "#         clinical_trial_summary = process_clinical_trial_data(json_data)\n",
    "#         clinical_trials_summaries.append(clinical_trial_summary)\n",
    "#     return clinical_trials_summaries\n",
    "\n",
    "# Make a "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Clinical Trial Summary:\n",
      "\n",
      "Conditions:\n",
      "• Breast Neoplasm Female\n",
      "\n",
      "Eligibility Criteria:\n",
      "Healthy Volunteers: False\n",
      "Sex: FEMALE\n",
      "Minimum Age: 18 Years\n",
      "Maximum Age: 75 Years\n",
      "Standard Ages: ['ADULT', 'OLDER_ADULT']\n",
      "\n",
      "Inclusion Criteria:\n",
      "\n",
      "* Female aged 18-75 years old.\n",
      "* ECOG 0 or 1 point.\n",
      "* Advanced triple-negative invasive breast cancer :\n",
      "\n",
      "  1. The pathological classification is triple negative, specifically:\n",
      "\n",
      "     1. ER negative: IHC\\<1%.\n",
      "     2. PR negative: IHC\\<1%.\n",
      "     3. HER2 negative: IHC-/+ or IHC++ but FISH/CISH is negative.\n",
      "  2. Tumor staging: locally advanced or recurrent/metastatic breast cancer.\n",
      "* If the last chemotherapy drug in the previous adjuvant/neoadjuvant treatment stage is paclitaxel, paclitaxel liposome, paclitaxel albumin or docetaxel, it will take ≥6 months from the end of treatment to enrollment.\n",
      "* At least one objectively measurable lesion according to the RECIST 1.1 .\n",
      "* The main organs are functioning well, and the blood test results within 14 days before enrollment should meet the following requirements:\n",
      "\n",
      "  1. Routine blood test:\n",
      "\n",
      "     1. Hemoglobin (HB) ≥90 g/L.\n",
      "     2. Neutrophil count (ANC) ≥1.5×109/L.\n",
      "     3. Platelet count (PLT) ≥100×109/L.\n",
      "  2. Biochemical test:\n",
      "\n",
      "     1. Total bilirubin≤1.5×ULN (upper limit of normal).\n",
      "     2. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5×ULN; if there is liver metastasis, ALT and AST ≤ 5×ULN.\n",
      "     3. Serum creatinine (Cr) ≤1.5 ULN or creatinine clearance ≥60mL/min.\n",
      "* Must not be regnant.\n",
      "* Volunteer to participate in this study and sign an informed consent form.\n",
      "\n",
      "Exclusion Criteria:\n",
      "\n",
      "* Pregnant, lactating or planning to become pregnant during the study period.\n",
      "* Allergic to any of the drugs in the study.\n",
      "* Previously received PD-1/PD-L1 antibody, CTLA-4 antibody, or anti-vascular targeted therapy.\n",
      "* Central nervous system (CNS) metastases.\n",
      "* Concomitant disease/medical history:\n",
      "\n",
      "  1. Patients with any known or suspected autoimmune diseases.\n",
      "  2. Hypertension.\n",
      "  3. Peripheral neuropathy ≥ Grade 2.\n",
      "  4. Persons with a history of unstable angina or arrhythmia.\n",
      "  5. Active or uncontrolled serious infection .\n",
      "  6. History of immunodeficiency.\n",
      "  7. Active hepatitis B or C.\n",
      "  8. interstitial lung disease or non-infectious pneumonia.\n",
      "  9. Active tuberculosis.\n",
      "  10. Urine protein is ≥++, and 24-hour urine protein quantitative is \\>1.0g.\n",
      "  11. Suffered from other malignant tumors within 5 years before enrollment.\n",
      "  12. Unreduced toxicity .\n",
      "  13. Multiple factors that affect oral medications.\n",
      "  14. Abnormal coagulation function.\n",
      "  15. Major surgical treatment, open biopsy or traumatic injury within 4 weeks.\n",
      "  16. Tumor has invaded the periphery of important blood vessels.\n",
      "  17. Patients who have seizures.\n",
      "  18. Bleeding constitution or medical history.\n",
      "  19. Arterial/venous thrombotic events before enrollment or within 6 months.\n",
      "  20. Live attenuated vaccine vaccination within 28 days before the study.\n",
      "  21. Uncontrollable pleural, abdominal or pericardial effusion.\n",
      "  22. Other uncontrollable systemic diseases.\n",
      "* Other serious physical or mental diseases or laboratory abnormalities.\n",
      "* Patients who the researcher thinks are not suitable for this research.\n",
      "* Participated in clinical trials of other anti-tumor drugs within four weeks.\n",
      "Clinical Trial Summary:\n",
      "\n",
      "Conditions:\n",
      "• Breast Neoplasm Female\n",
      "\n",
      "Eligibility Criteria:\n",
      "Healthy Volunteers: False\n",
      "Sex: FEMALE\n",
      "Minimum Age: 18 Years\n",
      "Maximum Age: 75 Years\n",
      "Standard Ages: ['ADULT', 'OLDER_ADULT']\n",
      "\n",
      "Inclusion Criteria:\n",
      "\n",
      "* Female aged 18-75 years old.\n",
      "* ECOG 0 or 1 point.\n",
      "* Advanced triple-negative invasive breast cancer :\n",
      "\n",
      "  1. The pathological classification is triple negative, specifically:\n",
      "\n",
      "     1. ER negative: IHC\\<1%.\n",
      "     2. PR negative: IHC\\<1%.\n",
      "     3. HER2 negative: IHC-/+ or IHC++ but FISH/CISH is negative.\n",
      "  2. Tumor staging: locally advanced or recurrent/metastatic breast cancer.\n",
      "* If the last chemotherapy drug in the previous adjuvant/neoadjuvant treatment stage is paclitaxel, paclitaxel liposome, paclitaxel albumin or docetaxel, it will take ≥6 months from the end of treatment to enrollment.\n",
      "* At least one objectively measurable lesion according to the RECIST 1.1 .\n",
      "* The main organs are functioning well, and the blood test results within 14 days before enrollment should meet the following requirements:\n",
      "\n",
      "  1. Routine blood test:\n",
      "\n",
      "     1. Hemoglobin (HB) ≥90 g/L.\n",
      "     2. Neutrophil count (ANC) ≥1.5×109/L.\n",
      "     3. Platelet count (PLT) ≥100×109/L.\n",
      "  2. Biochemical test:\n",
      "\n",
      "     1. Total bilirubin≤1.5×ULN (upper limit of normal).\n",
      "     2. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5×ULN; if there is liver metastasis, ALT and AST ≤ 5×ULN.\n",
      "     3. Serum creatinine (Cr) ≤1.5 ULN or creatinine clearance ≥60mL/min.\n",
      "* Must not be regnant.\n",
      "* Volunteer to participate in this study and sign an informed consent form.\n",
      "\n",
      "Exclusion Criteria:\n",
      "\n",
      "* Pregnant, lactating or planning to become pregnant during the study period.\n",
      "* Allergic to any of the drugs in the study.\n",
      "* Previously received PD-1/PD-L1 antibody, CTLA-4 antibody, or anti-vascular targeted therapy.\n",
      "* Central nervous system (CNS) metastases.\n",
      "* Concomitant disease/medical history:\n",
      "\n",
      "  1. Patients with any known or suspected autoimmune diseases.\n",
      "  2. Hypertension.\n",
      "  3. Peripheral neuropathy ≥ Grade 2.\n",
      "  4. Persons with a history of unstable angina or arrhythmia.\n",
      "  5. Active or uncontrolled serious infection .\n",
      "  6. History of immunodeficiency.\n",
      "  7. Active hepatitis B or C.\n",
      "  8. interstitial lung disease or non-infectious pneumonia.\n",
      "  9. Active tuberculosis.\n",
      "  10. Urine protein is ≥++, and 24-hour urine protein quantitative is \\>1.0g.\n",
      "  11. Suffered from other malignant tumors within 5 years before enrollment.\n",
      "  12. Unreduced toxicity .\n",
      "  13. Multiple factors that affect oral medications.\n",
      "  14. Abnormal coagulation function.\n",
      "  15. Major surgical treatment, open biopsy or traumatic injury within 4 weeks.\n",
      "  16. Tumor has invaded the periphery of important blood vessels.\n",
      "  17. Patients who have seizures.\n",
      "  18. Bleeding constitution or medical history.\n",
      "  19. Arterial/venous thrombotic events before enrollment or within 6 months.\n",
      "  20. Live attenuated vaccine vaccination within 28 days before the study.\n",
      "  21. Uncontrollable pleural, abdominal or pericardial effusion.\n",
      "  22. Other uncontrollable systemic diseases.\n",
      "* Other serious physical or mental diseases or laboratory abnormalities.\n",
      "* Patients who the researcher thinks are not suitable for this research.\n",
      "* Participated in clinical trials of other anti-tumor drugs within four weeks.\n"
     ]
    }
   ],
   "source": [
    "import textwrap\n",
    "\n",
    "# Update the function to use the new format_criteria function\n",
    "def format_clinical_trial_summary(summary):\n",
    "    \"\"\"\n",
    "    Generate a formatted summary for a clinical trial data dictionary.\n",
    "    \n",
    "    :param summary: dict, structured summary of extracted clinical trial information\n",
    "    :return: str, formatted summary suitable for presentation to a doctor\n",
    "    \"\"\"\n",
    "    # Helper function to format a list with bullet points\n",
    "    def format_list(items):\n",
    "        return \"\\n\".join(f\"• {item}\" for item in items)\n",
    "\n",
    "    # Helper function to wrap text for better readability\n",
    "    def wrap_text(text, width=80):\n",
    "        return \"\\n\".join(textwrap.wrap(text, width=width))\n",
    "\n",
    "    # Start building the formatted summary\n",
    "    formatted_summary = f\"Clinical Trial Summary:\\n\\n\"\n",
    "\n",
    "    # # Add identification information\n",
    "    # formatted_summary += f\"NCT ID: {summary['NCT ID']}\\n\"\n",
    "    # formatted_summary += f\"Brief Title: {wrap_text(summary['Brief Title'])}\\n\"\n",
    "    # formatted_summary += f\"Brief Summary: {wrap_text(summary['Brief Summary'])}\\n\"\n",
    "    # formatted_summary += f\"Official Title: {wrap_text(summary['Official Title'])}\\n\\n\"\n",
    "    \n",
    "    # Add conditions\n",
    "    formatted_summary += \"Conditions:\\n\"\n",
    "    formatted_summary += f\"{format_list(summary['Conditions'])}\\n\\n\"\n",
    "    \n",
    "    # # Add interventions\n",
    "    # formatted_summary += \"Interventions Description:\\n\"\n",
    "    # interventions_formatted = format_list(summary['Interventions Description'])\n",
    "    # formatted_summary += f\"{wrap_text(interventions_formatted, width=100)}\\n\\n\"\n",
    "    \n",
    "    # Add eligibility information\n",
    "    eligibility = summary['Eligibility']\n",
    "    formatted_summary += \"Eligibility Criteria:\\n\"\n",
    "    # For each key in eligibility, check if it's the criteria text and format accordingly\n",
    "    for key, value in eligibility.items():\n",
    "        if key == 'Criteria Text ':\n",
    "            # formatted_criteria = format_criteria(value)\n",
    "            # formatted_summary += wrap_text(formatted_criteria, width=100) + \"\\n\"\n",
    "            formatted_summary += '\\n' + value\n",
    "        else:\n",
    "            formatted_summary += f\"{key}: {wrap_text(str(value))}\\n\"\n",
    "    \n",
    "    return formatted_summary\n",
    "\n",
    "# Format the summary with the updated function\n",
    "formatted_summary = format_clinical_trial_summary(clinical_trial_summary)\n",
    "print(formatted_summary)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.15"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
